Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 4/20 | 0.67 |
| ▸ | PPARA | Q07869 | 6/20 | 0.62 |
| ▸ | PPARG | P37231 | 4/20 | 0.62 |
| ▸ | PPARD | Q03181 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7283024 | 1.00 | ACE (0.67) | ACEPPARAPPARGPPARD | |
| SCHEMBL7282451 | 1.00 | ACE (0.67) | ACEPPARAPPARGPPARD | |
| SCHEMBL9594476 | 0.92 | ACE (0.58) | ACEPPARAPPARGPPARD | |
| SCHEMBL11896626 | 0.91 | ACE (0.56) | ACEPPARAPPARGPPARD | |
| SCHEMBL13870212 | 0.88 | ACE (0.68) | ACEPPARAPPARG | |
| SCHEMBL27258933 | 0.87 | ACE (0.55) | ACEPPARAPPARG | |
| SCHEMBL12537197 | 0.87 | ACE (0.55) | ACEPPARAPPARGPPARD | |
| SCHEMBL14544522 | 0.87 | MAPT (0.54) | ACEPPARAPPARGPPARD | |
| SCHEMBL11555486 | 0.87 | ACE (0.69) | ACEPPARAPPARGPPARD | |
| SCHEMBL20817462 | 0.87 | ACE (0.69) | ACEPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240159775-A1 | WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-05-16 | — | — | US | claimed |
| CN-116148368-A | Method for detecting various environmental pollutants and oxidative damage markers in urine | 华中科技大学 | 2023-05-23 | — | — | CN | claimed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | claimed |
| US-20240159775-A1 | WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-05-16 | — | — | US | disclosed |
| US-11464784-B2 | Inhibition of aminocylase 3 (AA3) in the treatment of cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-10-11 | — | — | US | disclosed |
| US-20200206239-A1 | INHIBITION OF AMINOCYLASE 3 (AA3) IN THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-02 | — | — | US | disclosed |
| US-20190346449-A1 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2019-11-14 | — | — | US | disclosed |
| WO-2019055825-A1 | INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-03-21 | — | — | WO | disclosed |
| US-8227687-B2 | Quantum dot solar cell | HONEYWELL INTERNATIONAL INC. (US) | 2012-07-24 | — | — | US | disclosed |
| EP-2216839-A2 | Quantum dot solar cell | Honeywell International Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| EP-2216839-A2 | Quantum dot solar cell | Honeywell International Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| EP-0213785-A1 | Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl)ethylamine | NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) | 1987-03-11 | — | — | EP | disclosed |
| US-4394520-A | SKIN DISORDERS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1983-07-19 | — | — | US | disclosed |
| US-4204064-A | FOR TREATMENT OF SKIN OR SCALP | L'OREAL (FR) | 1980-05-20 | — | — | US | disclosed |
| US-4151301-A | ANTISECRETORY | L'OREAL (FR) | 1979-04-24 | — | — | US | disclosed |
| US-4139635-A | Cysteamine derivatives for oral treatment of seborrhea | L'OREAL (FR) | 1979-02-13 | — | — | US | disclosed |
| US-4085217-A | DERIVATIVES OF CYSTEINE OR CYSTEAMINE | L'OREAL (FR) | 1978-04-18 | — | — | US | disclosed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | disclosed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | disclosed |
| US-3950542-A | Cysteamine derivatives for oral treatment of seborrhea | L'OREAL (FR) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206239-A1 | INHIBITION OF AMINOCYLASE 3 (AA3) IN THE TREATMENT OF CANCER | PLAAT3, HCCS, LAP3 | ACE 836/4885PPARA 1777/4885PPARG 1762/4885 |
| US-11464784-B2 | Inhibition of aminocylase 3 (AA3) in the treatment of cancer | PLAAT3, HCCS, LAP3 | ACE 836/4885PPARA 1777/4885PPARG 1762/4885 |
| US-20190346449-A1 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | BTD, BTF3, PTMS | ACE 989/4885PPARA 3390/4885PPARG 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.